InnoScience (Suzhou) Technology Holding Co., Ltd. (abbrev. INNOSCIENCE) has obtained listing approval from Hong Kong Exchanges and Clearing Limited for the full circulation of its H shares. The Stock Exchange of Hong Kong granted the permission on 14 May 2026, enabling the company to convert and list 373.84 million domestic unlisted shares as H shares.

The conversion covers equity held by 35 participating shareholders, including major holders INNOSCIENCE HOLDING PTE. LTD. (43.00 million shares, 4.70% post-conversion), Shenzhen CMB Growth No.17 Equity Investment Fund L.P. (48.90 million shares, 5.34%), and Suzhou Wujiang Industrial Investment Co., Ltd. (44.75 million shares, 4.89%).

Share structure impact: • Pre-conversion: 389.56 million Domestic Unlisted Shares (42.57%) and 525.54 million H Shares (57.43%), totaling 915.10 million shares. • Post-conversion: Domestic Unlisted Shares will fall to 15.72 million (1.72%), while H Shares will surge to 899.38 million (98.28%), maintaining the total share count at 915.10 million.

INNOSCIENCE will complete the remaining procedural steps and will release further updates in line with Hong Kong Listing Rules and Inside Information provisions. Shareholders and potential investors are advised to exercise caution when dealing in the company’s shares.